Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Coward

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort StudyLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.
Journal of Crohn'S & Colitis|July 11, 2020
Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related ComplicationsLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.
Gastroenterology|September 27, 2021
Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-AnalysisJordan P Iannuzzi, James A King, Jessica Hope Leong, et al.
JAMA|November 29, 2017
Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical TrialDina Kao, Brandi Roach, Marisela Silva, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology-The Trends of Disease Over TimeStephanie Coward, Joseph W Windsor, M Ellen Kuenzig, et al.
Inflammatory Bowel Diseases|June 19, 2019
The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel DiseaseLaura E Targownik, Eric I Benchimol, Julia Witt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2023
Epidemiologic Burden and Projections for Eosinophilic Esophagitis-Associated Emergency Department Visits in the United States: 2009-2030Angela Y Lam, Jeffrey K Lee, Stephanie Coward, et al.
Journal of Medical Economics|July 3, 2026
TIME-trend and forecasting of the economic impact of inflammatory bowel disease in Catalonia: a population-based analysisBelén Garcia-Sagué, Eduard Brunet-Mas, Emili Vela, et al.
Ebiomedicine|July 3, 2017
The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only StudyM Ellen Kuenzig, Jeff Yim, Stephanie Coward, et al.
Inflammatory Bowel Diseases|January 15, 2022
The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend AnalysisGilaad G Kaplan, Fox E Underwood, Stephanie Coward, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort StudyLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.
Journal of Crohn'S & Colitis|July 11, 2020
Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related ComplicationsLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.
Gastroenterology|September 27, 2021
Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-AnalysisJordan P Iannuzzi, James A King, Jessica Hope Leong, et al.
JAMA|November 29, 2017
Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical TrialDina Kao, Brandi Roach, Marisela Silva, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology-The Trends of Disease Over TimeStephanie Coward, Joseph W Windsor, M Ellen Kuenzig, et al.
Inflammatory Bowel Diseases|June 19, 2019
The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel DiseaseLaura E Targownik, Eric I Benchimol, Julia Witt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2023
Epidemiologic Burden and Projections for Eosinophilic Esophagitis-Associated Emergency Department Visits in the United States: 2009-2030Angela Y Lam, Jeffrey K Lee, Stephanie Coward, et al.
Journal of Medical Economics|July 3, 2026
TIME-trend and forecasting of the economic impact of inflammatory bowel disease in Catalonia: a population-based analysisBelén Garcia-Sagué, Eduard Brunet-Mas, Emili Vela, et al.
Ebiomedicine|July 3, 2017
The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only StudyM Ellen Kuenzig, Jeff Yim, Stephanie Coward, et al.
Inflammatory Bowel Diseases|January 15, 2022
The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend AnalysisGilaad G Kaplan, Fox E Underwood, Stephanie Coward, et al.
Pageof 7